Myopridin (Pridinol Mesilate)

Pridinol mesilate, the active ingredient in Myopridin, is a muscle relaxant presented as an oral dosage form for oral use. It is employed to relieve muscle spasm, musculoskeletal pain and spasticity in adult patients. GNH USA supplies Myopridin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Myopridin is a centrally acting muscle relaxant used in conditions affecting skeletal muscle tone. - Muscle spasm: reduces involuntary contractions and associated discomfort. - Musculoskeletal pain: alleviates pain linked to over‑active muscle tone. - Spasticity: diminishes heightened muscle tone in neurological disorders.

Adverse reactions may occur with Myopridin use.

Common Side Effects: - Dry mouth: sensation of reduced salivation. - Drowsiness: mild to moderate sleepiness. - Dizziness: transient light‑headedness. - Gastrointestinal discomfort: nausea or mild abdominal pain.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Cardiac arrhythmia: irregular heart rhythm that may be life‑threatening. - Acute urinary retention: inability to void, especially in patients with prostate enlargement.

Before prescribing Myopridin, clinicians should consider several safety aspects. - Renal function assessment: adjust use in patients with impaired clearance. - Anticholinergic burden: monitor for excessive dry mouth, blurred vision or constipation. - Glaucoma caution: avoid in patients with narrow‑angle glaucoma. - Elderly patients: start with lower doses due to increased sensitivity. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Myopridin can interact with other medicines that affect the central nervous system or anticholinergic pathways.

Major Interactions (Avoid): - Other anticholinergic agents: may amplify anticholinergic side effects. - Additional centrally acting muscle relaxants: risk of excessive sedation and respiratory depression.

Moderate Interactions (Monitor Closely): - Alcohol: can enhance drowsiness and dizziness. - Antihistamines: may increase dry mouth and sedation. - Beta‑blockers: could mask tachycardia caused by anticholinergic effects.